WOEST
2013
What is the Optimal antiplatelet and anticoagulant therapy in patients with OAC and coronary StenTing
In 573 patients on oral anticoagulation undergoing PCI, clopidogrel without aspirin reduced bleeding compared with triple therapy.
Result
Efficacy: Any bleeding at 1 yearHR 0.36
Below 1 favours clopidogrel without aspirin, above 1 favours triple therapy.
- Absolute difference
- 25.0 points
The absolute difference is derived from the event rates.
Also reported: No increase in thrombotic events.
- Subtopic
- AF + PCI
- Design
- Open-label RCT
- Relevance
- Supporting: context rather than must-know.
- Cited in
- ESC 2024 CCSESC 2023 ACSESC/EACTS 2018 RevascularisationACC/AHA 2025 ACSACC/AHA 2021 Revascularisation
- Source
- Dewilde WJM, et al. Lancet. 2013;381(9872):1107-1115.doi 10.1016/S0140-6736(12)62177-1
Discussion & critique
First trial of 'less is more' antithrombotics: small, open-label, not powered for ischaemic events. Set a direction later confirmed decisively by AUGUSTUS.